Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Cell Transplantation (HCT)”

124 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 124 results

Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Testing effectiveness (Phase 2)Study completedNCT04151706
What this trial is testing

CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndromes+2 more
Robert Lowsky 7
Not applicableStudy completedNCT04645667
What this trial is testing

Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Who this might be right for
Acute GVHD
UNC Lineberger Comprehensive Cancer Center 38
Early research (Phase 1)Temporarily pausedNCT03467386
What this trial is testing

Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
City of Hope Medical Center 56
Testing effectiveness (Phase 2)Study completedNCT01772953
What this trial is testing

Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Center for International Blood and Marrow Transplant Research 40
Early research (Phase 1)UnknownNCT04429191
What this trial is testing

JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation

Who this might be right for
MYELODYSPLASTIC SYNDROME; MDSACUTE MYELOID LEUKEMIA; AML
Jasper Therapeutics, Inc. 40
Not applicableLooking for participantsNCT06649201
What this trial is testing

Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation

Who this might be right for
Graft Vs Host DiseaseVulvovaginal Signs and Symptoms
Case Comprehensive Cancer Center 40
Early research (Phase 1)Looking for participantsNCT07104799
What this trial is testing

Momelotinib During and After HCT in Myelofibrosis

Who this might be right for
MyelofibrosisHematopoietic Cell Transplantation (HCT)
Massachusetts General Hospital 28
Not applicableUnknownNCT04724642
What this trial is testing

COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency

Who this might be right for
Allogenic Hematopoietic Cell TransplantCAR-T TherapyPrimary Immunodeficiency
Tel-Aviv Sourasky Medical Center 110
Early research (Phase 1)Study completedNCT04139577
What this trial is testing

FMT In High-Risk Acute GVHD After ALLO HCT

Who this might be right for
Acute Graft-Versus-Host Disease (Gvhd) GradeHematopoietic Cell TransplantationFecal Microbiota Transplant
Massachusetts General Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT03720392
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)
Zachariah Michael DeFilipp 8
Testing effectiveness (Phase 2)Looking for participantsNCT07304232
What this trial is testing

Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)AML (Acute Myeloid Leukemia)
Institute of Hematology & Blood Diseases Hospital, China 134
Not applicableStudy completedNCT02077218
What this trial is testing

Computed Tomography and Biomarker Analysis in Diagnosing Coronary Artery Disease in Asymptomatic Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Cancer SurvivorDiabetes MellitusHypertension
City of Hope Medical Center 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07387367
What this trial is testing

Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

Who this might be right for
Adenovirus Infections
SymBio Pharmaceuticals 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT04692181
What this trial is testing

SYN-004 Safety and Tolerability in Allo-HCT Subjects

Who this might be right for
Acute Graft-Versus-Host Reaction Following Bone Marrow TransplantPrevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics
Theriva Biologics, Inc. 36
Not applicableStudy completedNCT01879072
What this trial is testing

Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Medical College of Wisconsin 1,860
Testing effectiveness (Phase 2)Looking for participantsNCT06271616
What this trial is testing

Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm
Mayo Clinic 40
Testing effectiveness (Phase 2)WithdrawnNCT05063123
What this trial is testing

Study to Assess an Interphase Cycle With Flotetuzumab.

Who this might be right for
AML
Stichting Hemato-Oncologie voor Volwassenen Nederland
Testing effectiveness (Phase 2)Study completedNCT01824693
What this trial is testing

Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia

Who this might be right for
Juvenile Myelomonocytic Leukemia
Children's Oncology Group 30
Testing effectiveness (Phase 2)Looking for participantsNCT03509961
What this trial is testing

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Pediatric Transplantation & Cellular Therapy Consortium 95
Load More Results